Which has the lower trailing P/E, BIO or PODD?

PODD has the lower trailing P/E: BIO trades at 42.72 and PODD at 26.39. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIO or PODD?

Over the past five years, PODD grew revenue faster — BIO at a 0.29% CAGR versus PODD at 25.13%.

Is BIO or PODD more profitable?

PODD runs the higher net margin — BIO at 8.59% versus PODD at 12.29%.

How have BIO and PODD total returns compared?

Over the past 10 years, BIO delivered 8.50% and PODD delivered 12.58% annualized total return. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs Insulet Corp. (PODD)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Insulet Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 10, 2026. Differences are shown without an overall score or investment verdict.

BIO

Bio-Rad Laboratories, Inc.

$9.49B

$352.47HealthcareDelayed quote: Aug 7, 2026, 4:00 PM EDT

PODD

Insulet Corp.

$9.78B

$141.17HealthcareDelayed quote: Aug 7, 2026, 4:00 PM EDT

Total return — BIO vs PODD

growth of $100 · dividends reinvested · last 10y

BIO +126.1% (+8.5%/yr)PODD +224.4% (+12.5%/yr)PODD compounded faster over this window

BIO PODD

BIO vs PODD: by the numbers

•PODD is the larger company ($9.78B vs $9.49B market cap).
•PODD trades at the lower trailing earnings multiple (26.39 vs 42.72 P/E), one valuation lens rather than an overall verdict.
•PODD converts more revenue to profit (12.29% vs 8.59% net margin).
•PODD grew revenue faster over the past five years (25.13% vs 0.29% CAGR).

Metrics side by side

Valuation

Metric	BIO	PODD
P/E ratio	42.72	26.39
Forward P/E	36.56	21.67
P/S ratio	3.65	3.23
P/B ratio	1.32	6.93
EV / EBITDA	26.59	16.43
FCF yield	3.74%	1.55%

Profitability

Metric	BIO	PODD
Gross margin	51.90%	71.08%
Operating margin	9.08%	16.89%
Net margin	8.59%	12.29%
ROE	3.10%	26.39%
ROIC	2.04%	13.62%

Growth (annualized)

Metric	BIO	PODD
Revenue CAGR (5Y)	0.29%	25.13%
EPS CAGR (5Y)	-26.27%	99.91%
FCF CAGR (5Y)	-9.65%	N/A
Total return CAGR (5Y)	-14.09%	-12.51%

Frequently asked

Which has the lower trailing P/E, BIO or PODD?: PODD has the lower trailing P/E: BIO trades at 42.72 and PODD at 26.39. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIO or PODD?: Over the past five years, PODD grew revenue faster — BIO at a 0.29% CAGR versus PODD at 25.13%.
Is BIO or PODD more profitable?: PODD runs the higher net margin — BIO at 8.59% versus PODD at 12.29%.
How have BIO and PODD total returns compared?: Over the past 10 years, BIO delivered 8.50% and PODD delivered 12.58% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full PODD analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio Insulet P/E ratio Bio-Rad Laboratories ROE Insulet ROE Bio-Rad Laboratories operating margin Insulet operating margin Bio-Rad Laboratories revenue growth Insulet revenue growth Bio-Rad Laboratories free cash flow Insulet free cash flow

Bio-Rad Laboratories & Insulet appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 10, 2026.